Substance-Related Disorders
Conditions
Interventions
Control group of 65 adolescents between 12 and 19 years old will receive the usual intervention for Substance Use Disorder treatment. Experimental group of 65 adolescents between 12 and 19 years old
Sponsors
Ministerio de Ciencia Tecnología e Innovación MINCIENCIAS
Universidad de Caldas
Eligibility
Age
12 Years to 19 Years
Inclusion criteria
Inclusion criteria: Time of abstinence greater than 15 days after the detoxification phase, validated by the unit's treating psychiatrist; Age between 12 and 19 years; Diagnosis of substance use disorder according to the Diagnostic and Statistical Manual of Mental Disorders; Ability to speak and read Spanish; Signed informed consent of parents and assent of patient
Exclusion criteria
Exclusion criteria: Intellectual disability documented by standardized cognitive testing or significant cognitive impairment according to the montreal cognitive assessment; hearing or visual impairments that prevent him/her from completing the instruments and understanding the support material; patients presenting psychosis at the time of evaluation; imminent risk of suicide; high risk of presenting withdrawal syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Greater reduction in drug use verified by physiological assessments and patterns of use, measured through the results of taking variability of heart rate, vital signs, height and weight, as well as the application of assessment scales for drug use, depression and anxiety, from 3 months after the intervention with the therapy of prevention of relapse based on full care;Reduced relapse time in the control group verified by readmissions to the psychiatric clinic, physiological assessments and consumption patterns, measured through the results of the measurement of heart rate variability, vital signs, height and weight, as well as the application of assessment scales for drug use, depression and anxiety, as an effect of intervention with traditional therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease of more than 20% in anxious depressive symptoms and perceived stress in the experimental group verified by physiological assessments and consumption patterns, measured through the results of cardiac frequency variability, vital signs, height and weight, as well as the application of drug use, depression and anxiety assessment scales. Data collected two days before the start of the intervention, at discharge and from 3 months after the intervention with the relapse prevention therapy based on full care;Greater reflection of the ability to regulate emotions in the post-intervention experimental group with the therapy of prevention of relapse based on mindfulness verified by significantly increased heart rate variability, vital signs, height and weight. | — |
Countries
Colombia
Contacts
Public ContactConsuelo Vélez Álvarez
Universidad de Caldas
Outcome results
None listed